Articles > Healthcare & Insurance
As the novel coronavirus COVID-19 continues to spread in the United States, many people are understandably concerned about access to their medications. Health officials and medical professionals working in federal, state and local governments recommend that high-risk individuals with underlying health conditions such as Type 1 Diabetes, stock up on their prescription medications, in addition to practicing basic hygiene and avoiding crowded places.
Last month, the FDA approved the Tandem Diabetes Care update to its t:slim X2 insulin pump Control-IQ technology, clearing the way for the first automated and interoperable insulin dosing system on the U.S. market.
Qualifying plans which offer the option of health savings accounts can provide pre-deductible coverage for some care for chronic conditions like diabetes, according to a new rule issued by the U.S. Treasury Department.
Dr. Sanjeev N. Mehta, a Joslin Diabetes Center pediatric endocrinologist, sees opportunity in standardizing patient data collection. He’s collaborating with the T1D Exchange Quality Improvement Collaborative to harness clinical data to improve diabetes care.